336 related articles for article (PubMed ID: 35306035)
1. Estimated GFR Slope Across CKD Stages in Primary Hyperoxaluria Type 1.
Singh P; Vaughan LE; Schulte PJ; Sas DJ; Milliner DS; Lieske JC
Am J Kidney Dis; 2022 Sep; 80(3):373-382. PubMed ID: 35306035
[TBL] [Abstract][Full Text] [Related]
2. Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.
Levey AS; Gansevoort RT; Coresh J; Inker LA; Heerspink HL; Grams ME; Greene T; Tighiouart H; Matsushita K; Ballew SH; Sang Y; Vonesh E; Ying J; Manley T; de Zeeuw D; Eckardt KU; Levin A; Perkovic V; Zhang L; Willis K
Am J Kidney Dis; 2020 Jan; 75(1):84-104. PubMed ID: 31473020
[TBL] [Abstract][Full Text] [Related]
3. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.
Swartling O; Rydell H; Stendahl M; Segelmark M; Trolle Lagerros Y; Evans M
Am J Kidney Dis; 2021 Aug; 78(2):190-199.e1. PubMed ID: 33434591
[TBL] [Abstract][Full Text] [Related]
4. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
5. Progressive Decline in Estimated GFR in Patients With Sickle Cell Disease: An Observational Cohort Study.
Derebail VK; Ciccone EJ; Zhou Q; Kilgore RR; Cai J; Ataga KI
Am J Kidney Dis; 2019 Jul; 74(1):47-55. PubMed ID: 30797615
[TBL] [Abstract][Full Text] [Related]
6. End Points for Clinical Trials in Primary Hyperoxaluria.
Milliner DS; McGregor TL; Thompson A; Dehmel B; Knight J; Rosskamp R; Blank M; Yang S; Fargue S; Rumsby G; Groothoff J; Allain M; West M; Hollander K; Lowther WT; Lieske JC
Clin J Am Soc Nephrol; 2020 Jul; 15(7):1056-1065. PubMed ID: 32165440
[TBL] [Abstract][Full Text] [Related]
7. Natural history of urine and plasma oxalate in children with primary hyperoxaluria type 1.
Sas DJ; Mara K; Mehta RA; Seide BM; Banks CJ; Danese DS; McGregor TL; Lieske JC; Milliner DS
Pediatr Nephrol; 2024 Jan; 39(1):141-148. PubMed ID: 37458799
[TBL] [Abstract][Full Text] [Related]
8. Cancer Risk and Mortality in Patients With Kidney Disease: A Population-Based Cohort Study.
Kitchlu A; Reid J; Jeyakumar N; Dixon SN; Munoz AM; Silver SA; Booth CM; Chan CTM; Garg AX; Amir E; Kim SJ; Wald R
Am J Kidney Dis; 2022 Oct; 80(4):436-448.e1. PubMed ID: 35405208
[TBL] [Abstract][Full Text] [Related]
9. Change in glomerular filtration rate over time in the Oxford Renal Cohort Study: observational study.
Hirst JA; Taal MW; Fraser SD; Mena JMO; O'Callaghan CA; McManus RJ; Taylor CJ; Yang Y; Ogburn E; Hobbs FR
Br J Gen Pract; 2022 Apr; 72(717):e261-e268. PubMed ID: 34990394
[TBL] [Abstract][Full Text] [Related]
10. Fast GFR decline and progression to CKD among primary care patients with preserved GFR.
Koraishy FM; Hooks-Anderson D; Salas J; Rauchman M; Scherrer JF
Int Urol Nephrol; 2018 Mar; 50(3):501-508. PubMed ID: 29404927
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing characteristics of pediatric patients with primary hyperoxaluria type 1 in PEDSnet.
Tasian GE; Dickinson K; Park G; Marchesani N; Mittal A; Cheng N; Ching CB; Chu DI; Walton R; Yonekawa K; Gluck C; Muneeruddin S; Kan KM; DeFoor W; Rove K; Forrest CB
J Pediatr Urol; 2024 Feb; 20(1):88.e1-88.e9. PubMed ID: 37848358
[TBL] [Abstract][Full Text] [Related]
12. Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
Michael M; Groothoff JW; Shasha-Lavsky H; Lieske JC; Frishberg Y; Simkova E; Sellier-Leclerc AL; Devresse A; Guebre-Egziabher F; Bakkaloglu SA; Mourani C; Saqan R; Singer R; Willey R; Habtemariam B; Gansner JM; Bhan I; McGregor T; Magen D
Am J Kidney Dis; 2023 Feb; 81(2):145-155.e1. PubMed ID: 35843439
[TBL] [Abstract][Full Text] [Related]
13. Rates of Reversal of Volume Overload in Hospitalized Acute Heart Failure: Association With Long-term Kidney Function.
McCallum W; Tighiouart H; Testani JM; Griffin M; Konstam MA; Udelson JE; Sarnak MJ
Am J Kidney Dis; 2022 Jul; 80(1):65-78. PubMed ID: 34843844
[TBL] [Abstract][Full Text] [Related]
14. CKD Progression From the Time of Estimated GFR-Based Waitlist Eligibility and Racial Disparities in Transplant Access.
Chu CD; Powe NR; Crews DC; Tuot DS
Am J Kidney Dis; 2022 Jun; 79(6):841-848.e1. PubMed ID: 34543686
[TBL] [Abstract][Full Text] [Related]
15. Health-Related Quality of Life according to Renal Function: Results from a Nationwide Health Interview and Examination Survey.
Faulhaber L; Herget-Rosenthal S; Jacobs H; Hoffmann F
Kidney Blood Press Res; 2022; 47(1):13-22. PubMed ID: 34818245
[TBL] [Abstract][Full Text] [Related]
16. Association of the Urine-to-Plasma Urea Ratio With CKD Progression.
Liu J; Bankir L; Verma A; Waikar SS; Palsson R
Am J Kidney Dis; 2023 Apr; 81(4):394-405. PubMed ID: 36356680
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure.
Zhao F; Bergstralh EJ; Mehta RA; Vaughan LE; Olson JB; Seide BM; Meek AM; Cogal AG; Lieske JC; Milliner DS;
Clin J Am Soc Nephrol; 2016 Jan; 11(1):119-26. PubMed ID: 26656319
[TBL] [Abstract][Full Text] [Related]
19. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T;
Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
